par admin | Oct 20, 2022 | News
The need for on-body delivery systems has been driven by several factors, for example: Development of high-value drugs that are biologics, and some of these biologics have either a viscosity or/and an infusion volume that are too high for being delivered by a syringe....
par admin | Août 25, 2022 | News
When developing your medical innovation, you need early on to define your targeted geographical areas. Most common targets for Swiss or European companies integrate Europe, the US and in some cases Asia (Japan and China). We never thought Debiotech expansion would go...
par admin | Juin 23, 2022 | News
Interested to know more about Debiotech ? Here are some key information about us. Localization Debiotech is a Swiss company based in Lausanne at the heart of the Health Valley. Through its history Debiotech has developed close partnerships with local institutions as...
par admin | Juin 9, 2022 | News
Better Quality of Life for People Living with Diabetes Through Innovative Artificial Intelligence Applications Through its ambitious research, the interdisciplinary consortium of 12 international partners will provide a digital solution for the management of...
par admin | Avr 25, 2022 | News
Debiotech, a leading Swiss innovation company in the field of medical devices, announced today that the VersiPD Cycler System, developed in close collaboration with its licensee Fresenius Medical Care, has received 510(k) clearance from the U.S. Food and Drug...
par admin | Mai 4, 2021 | News
2021 is a special year for Debiotech and synonymous of evolution. With more than 30 years of history, the company has recently decided to share its know-how in medical device development by focusing its activities around two main axes. Laurent-Dominique Piveteau,...
